People: Martek Biosciences Corp (MATK.O)

MATK.O on Nasdaq

20.39USD
9 Feb 2010
Price Change (% chg)

$0.39 (+1.95%)
Prev Close
$20.39
Open
--
Day's High
$20.49
Day's Low
$20.01
Volume
234,117
Avg. Vol
350,256
52-wk High
$25.43
52-wk Low
$15.36

view people for:

Summary

Name Age Since Current Position
Flanagan, Robert 53 2007 Chairman of the Board
Dubin, Steve 56 2006 Chief Executive Officer, Director
Abramson, David 56 2006 President
Buzy, Peter 50 2006 Chief Financial Officer, Executive Vice President - Finance and Administration, Treasurer
Nitze, Peter 51 2006 Chief Operating Officer, Executive Vice President
Feitel, David 46 2008 Executive Vice President, General Counsel
Easterling, Barney 64 2004 Senior Vice President - Manufacturing
MacMaster, Douglas 79 1993 Director
Rotberg, Eugene 80 1992 Director
Keller, Jerome 67 2005 Director
Beery, James 68 2004 Director
Kawalek, Polly 55 2006 Director
D'Andrea, Harry 53 2006 Director
Mayer, Robert 66 2008 Director
Devine, Michael 57 2008 Director
Pernock, David 55 2009 Director
» Insider Trading

Biographies

Name Description
Flanagan, Robert Mr. Robert J. Flanagan is Chairman of the Board of Martek Biosciences Corp. Mr. Flanagan has been a director of Martek since April 2002 & he has been member of Compensation Committee, Nominating and Corporate Governance Committee. Mr. Flanagan has been Executive Vice President of Clark Enterprises, Inc. ("Clark"), a Bethesda, Maryland-based holding company, since 1989. Clark is the ownership, investment and asset management arm of various Clark entities, including one of the privately-held construction companies in the United States. Prior to joining Clark, Mr. Flanagan was Treasurer, Secretary and a member of the Board of Directors of Baltimore Orioles, Inc. from 1981 to 1989. He was also employed from 1978 to 1981 as a member of Arthur Andersen's audit division in its Washington, D.C. office.
Dubin, Steve Mr. Steve Dubin is Chief Executive Officer, Director of Martek Biosciences Corp. Mr. Dubin has been a director of Martek since July 2006. Mr. Dubin became Chief Executive Officer of Martek in June 2006 after serving since September 2003 as President of Martek. Mr. Dubin joined Martek in 1992 and has served in various management positions, including Chief Financial Officer, Treasurer, Secretary, General Counsel and Senior Vice President of Business Development. In 2000, he moved to a part-time position of Senior Advisor—Business Development, a role he filled until his election to President of Martek in September 2003. He also spent time during 2000 through 2003 co-founding and co-managing a Maryland-based, angel-investing club that funds early-stage, high-potential businesses. He was also "Of Counsel" to the law firm Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. during part of 2001 and 2002. Prior to 1992, Mr. Dubin worked in the financing and management of early-stage businesses and, over a period of 12 years, served in various positions at Suburban Bank, now part of Bank of America, including Vice President and Treasurer of its venture capital subsidiary, Suburban Capital Corporation.
Abramson, David Mr. David M. Abramson is President of Martek Biosciences Corp. Mr. Abramson joined Martek in 2003 as head of Corporate Development and was elected President in September 2006. Prior to joining Martek, he was the Executive Vice President and General Counsel for U.S. Foodservice from 1996 to 2003. In this position, Mr. Abramson oversaw the legal and regulatory affairs of U.S. Foodservice, a foodservice distributor in the United States, and advised on business development opportunities for this company. U.S. Foodservice became a subsidiary of Royal Ahold in 2000. In addition, Mr. Abramson was also the Executive Vice President for Legal Affairs at Ahold, U.S.A. from 2000 to 2003. Mr. Abramson also served on the Board of Directors of U.S. Foodservice from 1994 to 2003. Prior to joining U.S. Foodservice, from 1983 until 1996, Mr. Abramson was a partner at Levan, Schimel, Belman & Abramson, P.A., now a part of Miles & Stockbridge P.C. Mr. Abramson graduated from George Washington University in 1975, where he obtained a Bachelor of Business Administration in accounting. He received his Juris Doctor degree, with honors, from the University of Maryland School of Law in 1978. Mr. Abramson is a member of the Maryland Bar.
Buzy, Peter Mr. Peter L. Buzy is Chief Financial Officer, Executive Vice President - Finance and Administration, Treasurer of Martek Biosciences Corp. Mr. Buzy joined Martek in 1998 as Chief Financial Officer. Prior to joining Martek, Mr. Buzy spent 13 years with the accounting firm of Ernst & Young LLP, most recently as an audit partner in the Northern Virginia High Technology/Life Sciences Practice. Mr. Buzy is a Certified Public Accountant and a member of the American Institute of Certified Public Accountants. He received his B.S. in accounting from Salisbury University.
Nitze, Peter Mr. Peter A. Nitze is Chief Operating Officer, Executive Vice President of Martek Biosciences Corp. Mr. Nitze joined Martek in 2005 as Chief Operating Officer. Prior to joining Martek, Mr. Nitze served as Vice President of Operations at DRS Technologies from April 2004 to July 2005, with responsibility for the alignment and deployment of the company's manufacturing and supply chain resources. Before joining DRS Technologies, Mr. Nitze served as the Chief Operating Officer of Regulatory DataCorp, a New York City firm that provides risk management services to financial services institutions, from July 2002 to April 2004. Prior to joining Regulatory DataCorp, Mr. Nitze was the business leader of the Optoelectronics venture at Honeywell International from February 2000 to November 2001, where he had previously served as the head of global operations for the Amorphous Metals division. Mr. Nitze began his career at General Electric Co. in finance and subsequently held a variety of positions in engineering, marketing, supply chain and operations management. He holds two M.S. degrees in engineering from Stanford University and a B.A. degree from Harvard University.
Feitel, David Mr. David M. Feitel is Executive Vice President, General Counsel of Martek Biosciences Corp. Mr. Feitel joined Martek in 2004 as Associate General Counsel and was elected to the position of Senior Vice President and General Counsel in December 2006 and later to Executive Vice President and General Counsel in November 2008. From 2003 until joining Martek, he practiced law at Miles & Stockbridge P.C., where he had started his legal career in 1988. From 2000 to 2003, Mr. Feitel was the Vice President and General Counsel of BCE Emergis, an eCommerce service provider and a subsidiary of Bell Canada. Prior to BCE Emergis, Mr. Feitel worked for the Discovery Group, a Columbus, Ohio-based venture capital company, from 1997 through 2000. Mr. Feitel received his undergraduate degree from Duke University and his Juris Doctor from the Duke University School of Law in 1988.
Easterling, Barney Mr. Barney B. Easterling is Senior Vice President - Manufacturing of Martek Biosciences Corp. Mr. Easterling joined Martek in 2003 in connection with Martek's acquisition of FermPro Manufacturing, LP ("FermPro"). With the acquisition, he was named Vice President of Manufacturing of Martek, and in March 2004, he was elected to the position of Senior Vice President of Manufacturing. From 1994 to 2003, Mr. Easterling served as President and CEO of FermPro, a provider of contract fermentation services. From 1980 to 1994, Mr. Easterling served in various management capacities for Gist-Brocades. He received a B.S. in premedicine from Clemson University.
MacMaster, Douglas Mr. Douglas J. MacMaster Jr., is Director of Martek Biosciences Corp., since 1993. Mr. MacMaster is member of Nominating and Corporate Governance Committee, Chairman of Compensation Committee. Mr. MacMaster, who is currently retired, served in various management positions at Merck from 1961 to 1988, during which time he was appointed Senior Vice President responsible for ten divisions, including Manufacturing and Technology and Pharmaceutical Manufacturing. Mr. MacMaster retired from Merck in 1991.
Rotberg, Eugene Mr. Eugene H. Rotberg is Director of Martek Biosciences Corp., since 1992. Mr. Rotberg is member of Audit Committee, Nominating and Corporate Governance Committee. Mr. Rotberg has been an independent advisor to international development and financial institutions since 1990. From 1987 to 1990, Mr. Rotberg was Executive Vice President and a member of the Executive Committee at Merrill Lynch & Co., Inc. From 1969 to 1987, Mr. Rotberg was Vice President and Treasurer of the World Bank.
Keller, Jerome Mr. Jerome C. Keller is Director of Martek Biosciences Corp., since 1993. Mr. Keller, who is currently retired, served as Martek's Senior Vice President, Sales and Marketing from 1997 until his retirement in 2005. Prior to joining Martek, Mr. Keller had been consulting after spending a 25-year career at Merck & Co., Inc. ("Merck"), most recently as Vice President of Sales from 1986 to 1993. Mr. Keller also serves as a director of WebMD Health Corp.
Beery, James Mr. James R. Beery is Director of Martek Biosciences Corp., since March 2004. Mr. Beery is Chairman of Nominating and Corporate Governance Committee. Mr. Beery served as Senior Vice President and General Counsel for SmithKline Beecham and subsequently GlaxoSmithKline (GSK) from 1993 until his retirement in 2001. Following his retirement from GSK, Mr. Beery became, and currently serves as, Senior Of Counsel to the London office of Covington & Burling LLP. Mr. Beery also serves as a director of DGI Resolution, Inc., a biotechnology, drug discovery company, and Orchid Cellmark, Inc., a genetic testing company.
Kawalek, Polly Ms. Polly B. Kawalek is Director of Martek Biosciences Corp., since January 2006. Ms. Kawalek is member of Audit Committee, Compensation Committee. Ms. Kawalek, who is currently retired, served for 25 years in various capacities at Quaker Oats, Inc., a consumer goods company and, since 2001, a business unit of PepsiCo. From 2002 until her retirement in 2004, she served as President of PepsiCo's Quaker Foods division. In 2001, Ms. Kawalek served as President of Quaker Oats' U.S. Foods division and from 1997 through 2000, she served as President of the Hot Breakfast division. Ms. Kawalek also serves as director for John Bean Technologies, Inc.
D'Andrea, Harry Mr. Harry J. D'Andrea is Director of Martek Biosciences Corp., since November 2006. Mr. D'Andrea is Chairman of Audit Committee. Mr. D'Andrea has served as Administrative General Partner of Valhalla Partners, a venture capital fund, since 2002. From 1999 to 2002, Mr. D'Andrea served as the Chief Financial Officer of Advanced Switching Communications, Inc., a telecommunications equipment provider. From 1998 to 1999, Mr. D'Andrea served as Chief Financial Officer of Call Technologies, Inc., a telecommunications software provider. From 1997 to 1998, Mr. D'Andrea served as Chief Financial Officer of Yurie Systems, Inc., a provider of networking and telecommunications equipment.
Mayer, Robert Mr. Robert H. Mayer is Director of Martek Biosciences Corp., since January 2008. Mr. Mayer is member of Compensation Committee. Mr. Mayer has been an independent management consultant since 2007. From 1981 to 2007, Mr Mayer served in various executive capacities for Danisco A/S, one of the world's producers of ingredients for food and other consumer products. From 2005 to 2007, Mr. Mayer served as Chief Executive Officer and Chairman of the Board for Genencor International, Inc., a wholly-owned subsidiary of Danisco A/S specializing in the development and manufacture of industrial enzymes. From 1999 to 2005, Mr. Mayer served as Executive Vice President and Chief Operating Officer of Danisco's Food Ingredients Division and from 1981 to 1999, Mr. Mayer served as President of Danisco USA, Inc.
Devine, Michael Mr. Michael G. Devine is Director of Martek Biosciences Corp., since May 2008. Mr. Devine is member of Audit Committee. Mr. Devine has been an independent financial and management consultant since 2007, and prior to that from 2003 to 2004. From 2004 until 2007, Mr. Devine was the Chief Financial Officer of Secure Software, Inc., a software developer. Prior to 2003, Mr. Devine spent 24 years in public accounting serving as a partner with Arthur Andersen LLP, and later with Deloitte & Touche LLP.
Pernock, David Mr. David M. Pernock is Director of Martek Biosciences Corp., since September 2009. Mr. Pernock has been Chairman of the Board of Fibrocell Science, Inc., a biotech dermatology company, since September 2009 and became Chief Executive Officer in February 2010. Previously, Mr. Pernock served in a variety of executive capacities for GSK from 1994 to 2009, including most recently as Senior Vice President of Pharmaceuticals, Vaccines (Biologics), Oncology, Acute Care, and HIV Divisions of GSK's U.S. operations. Prior to his appointment as Senior Vice President, Mr. Pernock had served as Vice President of Marketing—Pharmaceuticals, Vice President of Sales and Marketing—Oncology, Vice President, Managed Care, and Vice President, Sales. Mr. Pernock holds a Bachelor of Science degree in Business Administration from Arizona State University.

Basic Compensation

Name Fiscal Year Total
Flanagan, Robert --
Dubin, Steve 929,465
Abramson, David 726,684
Buzy, Peter 721,722
Nitze, Peter 843,243
Feitel, David 583,306
Easterling, Barney 742,741
MacMaster, Douglas --
Rotberg, Eugene --
Keller, Jerome 439,179
Beery, James --
Kawalek, Polly --
D'Andrea, Harry --
Mayer, Robert --
Devine, Michael --
Pernock, David --
As Of 30 Oct 2009

Options Compensation

Name Options Value
Flanagan, Robert 0 0
Dubin, Steve 100,733 196,596
Abramson, David 45,000 0
Buzy, Peter 298,000 1,707,700
Nitze, Peter 25,000 0
Feitel, David 0 0
Easterling, Barney 0 0
MacMaster, Douglas 0 0
Rotberg, Eugene 0 0
Keller, Jerome 305,000 6,571,190
Beery, James 0 0
Kawalek, Polly 0 0
D'Andrea, Harry 0 0
Mayer, Robert 0 0
Devine, Michael 0 0
Pernock, David 0 0

Insider Trading

Name Shares Traded Price
BUZY PETER L 1,000 $0.00
MACMASTER DOUGLAS J JR 4,907 $23.80
FEALEY TERENCE 1,634 $0.00
FEALEY TERENCE 531 $24.43
DEVINE MICHAEL G 1,755 $0.00
FEALEY TERENCE 349 $17.07
EASTERLING BARNEY B JR 941 $17.07
BUZY PETER L 4,795 $0.00
FEITEL DAVID M 2,520 $0.00
DUBIN STEVE 2,131 $17.07
FEALEY TERENCE 1,074 $0.00
EASTERLING BARNEY B JR 2,694 $0.00
ABRAMSON DAVID M 1,651 $17.07
NITZE PETER A 1,557 $17.07
DUBIN STEVE 6,191 $0.00
BUZY PETER L 1,651 $17.07
FEITEL DAVID M 898 $17.07
ABRAMSON DAVID M 4,795 $0.00
NITZE PETER A 4,795 $0.00
FLANAGAN ROBERT J 2,034 $0.00
D ANDREA HARRY J 2,034 $0.00
ROTBERG EUGENE H 2,034 $0.00
MAYER ROBERT H 2,034 $0.00
KELLER JEROME C 2,034 $0.00
BEERY JAMES 2,034 $0.00
» Full list on Insider Trading
view people for: